Advancing research for better health
MSD (ternspharma.com) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 59th percentile of 20324 Healthcare brands.
MSD is an American multinational pharmaceutical company, founded in 1891 and headquartered in Kenilworth. It focuses on biopharmaceutical research, with particular attention to addressing unmet needs in retinal diseases and other complex health conditions. The company positions itself as a global leader in medical innovation, serving patients, caregivers, healthcare providers, and investors through research-driven healthcare solutions.
| Brand Name | MSD |
|---|---|
| Domain | ternspharma.com |
| Industry | Healthcare |
| Founded | 1891 |
| Headquarters | Kenilworth |
| Parent Company / Owner | The Vanguard Group |
| CEO | Kenneth Frazier |
| Main Competitors | Pfizer (89/100), Johnson & Johnson (87/100), Novartis (75/100), Roche (81/100), Sanofi (90/100), AbbVie (83/100), Bristol-Myers Squibb (89/100), Regeneron (92/100), GlaxoSmithKline (83/100) |
Moz Domain Authority 36/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,152,200 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
MSD has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "At MSD, we" (Meta description too short (3 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, LinkedIn, Instagram, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
MSD's main competitors in Healthcare: Pfizer (89/100), Johnson & Johnson (87/100), Novartis (75/100), Roche (81/100), Sanofi (90/100).
Sources: Brand Analyzer scan
MSD has moderate AI-search visibility, scoring 56/100 on Brand Analyzer's AI visibility composite (visibility 65, trust 54, recommendation 44). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: MSD official site
MSD was founded in 1891. MSD operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
MSD is headquartered in Kenilworth. MSD operates in the Healthcare category.
Sources: Wikidata
MSD scores 44/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: MSD official site
MSD can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: MSD official site
MSD is owned by or part of The Vanguard Group. MSD operates in the Healthcare category.
Sources: Wikidata
MSD is an American multinational pharmaceutical company founded in 1891 and headquartered in Kenilworth. It operates in the healthcare sector, conducting biopharmaceutical research aimed at developing treatments for various medical conditions, including retinal diseases.
Sources: MSD official site
MSD scores 56/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
MSD has a limited AI-visibility profile at 56/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (65/100) and its weakest is recommendation likelihood (44/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #2,152,200 (Tranco). The main gaps holding it back: a low Moz Domain Authority of 36/100 and no llms.txt to steer AI to its best pages.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to MSD: Tergooi MC (77/100), Tenacore (77/100), TerraLeads (77/100), Terra Nuova (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.